Rituximab for ANCA Associated Vasculitis (AAV): Contender for top 10 of 2013
In a year which gave us the bardoxolone failure, NEPHRON-D and the CORAL trial to name a few, a study with a positive result should be celebrated and the RAVE follow-up must be a contender for top 10…